{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:00:11Z","timestamp":1788328811969,"version":"build-2803163510"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Experimental \u2013 Research Center ELPEN Pharmaceuticals"},{"name":"EU-CARDIOPROTECTION COST-Action","award":["CA16225"],"award-info":[{"award-number":["CA16225"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/cvr\/cvz061","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T20:14:40Z","timestamp":1551471280000},"page":"1228-1243","source":"Crossref","is-referenced-by-count":34,"title":["Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors"],"prefix":"10.1093","volume":"115","author":[{"given":"Panagiota-Efstathia","family":"Nikolaou","sequence":"first","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Boengler","sequence":"additional","affiliation":[{"name":"Institute for Physiology, Justus-Liebig University Giessen, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Efentakis","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"},{"name":"Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Vouvogiannopoulou","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Zoga","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Medical School, Attikon University Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gaboriaud-Kolar","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"},{"name":"Bioval Oc\u00e9an Indien, Montpellier Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Myrianthopoulos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Alexakos","sequence":"additional","affiliation":[{"name":"Academy of Athens Biomedical Research Foundation, Centre of Clinical Experimental Surgery and Translational Research, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kostomitsopoulos","sequence":"additional","affiliation":[{"name":"Academy of Athens Biomedical Research Foundation, Centre of Clinical Experimental Surgery and Translational Research, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Rerras","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tsantili-Kakoulidou","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios Leandros","family":"Skaltsounis","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Papapetropoulos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"},{"name":"Academy of Athens Biomedical Research Foundation, Centre of Clinical Experimental Surgery and Translational Research, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios K","family":"Iliodromitis","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Medical School, Attikon University Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Schulz","sequence":"additional","affiliation":[{"name":"Institute for Physiology, Justus-Liebig University Giessen, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Andreadou","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Faculty of Pharmacy, Panepistimiopolis, Zografou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"2019052205000879900_cvz061-B1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur Heart J"},{"key":"2019052205000879900_cvz061-B2","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/bph.12902","article-title":"Extracellular signalling molecules in the ischaemic\/reperfused heart\u2014druggable and translatable for cardioprotection?","volume":"172","author":"Kleinbongard","year":"2015","journal-title":"Br J Pharmacol"},{"key":"2019052205000879900_cvz061-B3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium","volume":"74","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"2019052205000879900_cvz061-B4","doi-asserted-by":"crossref","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","article-title":"Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning","volume":"285","author":"Zhao","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205000879900_cvz061-B5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","article-title":"Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial","volume":"375","author":"B\u00f8tker","year":"2010","journal-title":"Lancet"},{"key":"2019052205000879900_cvz061-B6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/138955708785132819","article-title":"Pharmacological pre- and post-conditioning agents: reperfusion-injury of the heart revisited","volume":"8","author":"Andreadou","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"2019052205000879900_cvz061-B7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2019052205000879900_cvz061-B8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/01.RES.0000012567.95445.55","article-title":"Phosphorylation of glycogen synthase kinase-3\u03b2 during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective","volume":"90","author":"Tong","year":"2002","journal-title":"Circ Res"},{"key":"2019052205000879900_cvz061-B9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","article-title":"Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation","volume":"12","author":"Hughes","year":"1993","journal-title":"EMBO J"},{"key":"2019052205000879900_cvz061-B10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/35096075","article-title":"The renaissance of GSK3","volume":"2","author":"Cohen","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019052205000879900_cvz061-B11","doi-asserted-by":"crossref","first-page":"H1215","DOI":"10.1152\/ajpheart.00124.2018","article-title":"Mitochondria \u201cTHE\u201d target of myocardial conditioning","volume":"315","author":"Boengler","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205000879900_cvz061-B12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2014.12.001","article-title":"Physiological and pathological roles of the mitochondrial permeability transition pore in the heart","volume":"21","author":"Kwong","year":"2015","journal-title":"Cell Metab"},{"key":"2019052205000879900_cvz061-B13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4330\/wjc.v3.i6.186","article-title":"Ischemia\/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species","volume":"3","author":"Perrelli","year":"2011","journal-title":"World J Cardiol"},{"key":"2019052205000879900_cvz061-B14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"Juhaszova","year":"2004","journal-title":"J Clin Invest"},{"key":"2019052205000879900_cvz061-B15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yjmcc.2014.08.015","article-title":"Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury","volume":"78","author":"Morciano","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205000879900_cvz061-B16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fonc.2013.00025","article-title":"What makes you can also break you: mitochondrial permeability transition pore formation by the c subunit of the F1F0 ATP-synthase?","volume":"3","author":"Chinopoulos","year":"2013","journal-title":"Front Oncol"},{"key":"2019052205000879900_cvz061-B17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCRESAHA.111.249532","article-title":"Differential roles of GSK-3\u03b2 during myocardial ischemia and ischemia\/reperfusion","volume":"109","author":"Zhai","year":"2011","journal-title":"Circ Res"},{"key":"2019052205000879900_cvz061-B18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10495-017-1376-0","article-title":"Role of glycogen synthase kinase following myocardial infarction and ischemia\u2013reperfusion","volume":"22","author":"Ghaderi","year":"2017","journal-title":"Apoptosis"},{"key":"2019052205000879900_cvz061-B19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem J"},{"key":"2019052205000879900_cvz061-B20","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/sj.onc.1209648","article-title":"7-Bromoindirubin-3\u2032-oxime induces caspase-independent cell death","volume":"25","author":"Ribas","year":"2006","journal-title":"Oncogene"},{"key":"2019052205000879900_cvz061-B21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jm031016d","article-title":"Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases","volume":"47","author":"Polychronopoulos","year":"2004","journal-title":"J Med Chem"},{"key":"2019052205000879900_cvz061-B22","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm800648y","article-title":"Soluble 3\u2032,6-substituted indirubins with enhanced selectivity towards glycogen synthase kinase-3 alter circadian period","volume":"51","author":"Vougogiannopoulou","year":"2008","journal-title":"J Med Chem"},{"key":"2019052205000879900_cvz061-B23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.freeradbiomed.2006.06.021","article-title":"Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation","volume":"41","author":"Andreadou","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"2019052205000879900_cvz061-B24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cvr\/cvs121","article-title":"Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress","volume":"94","author":"Andreadou","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2019052205000879900_cvz061-B25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvv129","article-title":"Cardioprotection by H2S engages a cGMP-dependent protein kinase G\/phospholamban pathway","volume":"106","author":"Bibli","year":"2015","journal-title":"Cardiovasc Res"},{"key":"2019052205000879900_cvz061-B26","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1080\/21505594.2018.1532242","article-title":"Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents","volume":"9","author":"Efstathiou","year":"2018","journal-title":"Virulence"},{"key":"2019052205000879900_cvz061-B27","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","article-title":"Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects","volume":"8","author":"Andreadou","year":"2017","journal-title":"Front Physiol"},{"key":"2019052205000879900_cvz061-B28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/jpet.116.235119","article-title":"Cardioprotection by H2S donors: nitric oxide-dependent and -independent mechanisms","volume":"358","author":"Chatzianastasiou","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"2019052205000879900_cvz061-B29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"2019052205000879900_cvz061-B30","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/bph.13804","article-title":"The gap junction modifier ZP1609 decreases cardiomyocyte hypercontracture following ischaemia\/reperfusion independent from mitochondrial connexin 43","volume":"174","author":"Boengler","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2019052205000879900_cvz061-B31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00395-009-0007-5","article-title":"Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria","volume":"104","author":"Boengler","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"2019052205000879900_cvz061-B32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vascn.2018.01.004","article-title":"Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria leads to artefacts in mitochondrial protein quantification","volume":"91","author":"Koncsos","year":"2018","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2019052205000879900_cvz061-B33","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.755066","article-title":"Inhibition of GSK3\u03b2 by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion","volume":"117","author":"Gomez","year":"2008","journal-title":"Circulation"},{"key":"2019052205000879900_cvz061-B34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/17460441.2016.1160886","article-title":"Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery","volume":"11","author":"Tsopelas","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"2019052205000879900_cvz061-B35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/978-1-4939-1875-1_7","article-title":"Determination of oxidative phosphorylation complexes activities","volume-title":"Mitochondrial Regulation Methods and Protocols","author":"Teodoro","year":"2015"},{"key":"2019052205000879900_cvz061-B36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"2019052205000879900_cvz061-B37","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1242\/jcs.03468","article-title":"Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death","volume":"120","author":"Lee","year":"2007","journal-title":"J Cell Sci"},{"key":"2019052205000879900_cvz061-B38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1078-0432.CCR-10-0752","article-title":"p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies","volume":"17","author":"Wander","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2019052205000879900_cvz061-B39","doi-asserted-by":"crossref","first-page":"505607.","DOI":"10.4061\/2011\/505607","article-title":"What are the bona fide GSK3 substrates?","volume":"2011","author":"Sutherland","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"2019052205000879900_cvz061-B40","doi-asserted-by":"crossref","first-page":"29285","DOI":"10.1074\/jbc.M114.563924","article-title":"Translocation of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2)","volume":"289","author":"Tanno","year":"2014","journal-title":"J Biol Chem"},{"key":"2019052205000879900_cvz061-B41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.yjmcc.2007.08.010","article-title":"Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection","volume":"43","author":"Nishihara","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205000879900_cvz061-B42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/etm.2017.4457","article-title":"Pharmacological postconditioning with atorvastatin calcium attenuates myocardial ischemia\/reperfusion injury in diabetic rats by phosphorylating GSK3\u03b2","volume":"14","author":"Chen","year":"2017","journal-title":"Exp Ther Med"},{"key":"2019052205000879900_cvz061-B43","doi-asserted-by":"crossref","first-page":"H2056","DOI":"10.1152\/ajpheart.00403.2007","article-title":"Local delivery of PKC\u03b5-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3\u03b2 but not F1-ATPase inactivation","volume":"293","author":"Korzick","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205000879900_cvz061-B44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.107.169953","article-title":"Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse","volume":"103","author":"Nishino","year":"2008","journal-title":"Circ Res"},{"key":"2019052205000879900_cvz061-B45","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/bph.12959","article-title":"The cGMP\/PKG pathway as a common mediator of cardioprotection: translatability and mechanism","volume":"172","author":"Inserte","year":"2015","journal-title":"Br J Pharmacol"},{"key":"2019052205000879900_cvz061-B46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol Ther"},{"key":"2019052205000879900_cvz061-B47","doi-asserted-by":"crossref","first-page":"H1497","DOI":"10.1152\/ajpheart.01381.2007","article-title":"Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion","volume":"294","author":"Gross","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205000879900_cvz061-B48","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/317456","article-title":"GSK-3\u03b2 inhibitors mimic the cardioprotection mediated by ischemic pre- and postconditioning in hypertensive rats","volume":"2013","author":"Gonz\u00e1lez Arbel\u00e1ez","year":"2013","journal-title":"Biomed Res Int"},{"key":"2019052205000879900_cvz061-B49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ Res"},{"key":"2019052205000879900_cvz061-B50","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2005.09.009","article-title":"Glycogen synthase kinase-3\u03b2\/\u03b2-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium","volume":"40","author":"Kaga","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205000879900_cvz061-B51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/cdd.2015.101","article-title":"The SR\/ER-mitochondria calcium crosstalk is regulated by GSK3\u03b2 during reperfusion injury","volume":"23","author":"Gomez","year":"2016","journal-title":"Cell Death Differ"},{"key":"2019052205000879900_cvz061-B52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cvr\/cvr002","article-title":"GSK-3\u03b2 at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways","volume":"90","author":"Vigneron","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2019052205000879900_cvz061-B53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/cvr\/cvy222","article-title":"Nitroglycerin limits infarct size through S-nitrosation of Cyclophilin D: a novel mechanism for an old drug","volume":"115","author":"Bibli","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2019052205000879900_cvz061-B54","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/cns.12016","article-title":"AKT\/GSK3\u03b2-dependent autophagy contributes to the neuroprotection of limb remote ischemic postconditioning in the transient cerebral ischemic rat model","volume":"18","author":"Qi","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"2019052205000879900_cvz061-B55","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2018-06-858415","article-title":"Molecular mechanisms of Carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of Metformin","volume":"133","author":"Efentakis","year":"2019","journal-title":"Blood"},{"key":"2019052205000879900_cvz061-B56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/pros.23106","article-title":"Gsk-3\u03b2 controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells","volume":"76","author":"Sun","year":"2016","journal-title":"Prostate"},{"key":"2019052205000879900_cvz061-B57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","article-title":"The GSK-3 family as therapeutic target for myocardial diseases","volume":"116","author":"Lal","year":"2015","journal-title":"Circ Res"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/115\/7\/1228\/28679684\/cvz061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:58:54Z","timestamp":1721033934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/115\/7\/1228\/5370550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,29]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvz061","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2019,3,29]]}}}